ALS Ltd (ASX: ALQ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ALS Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ALS Ltd (ASX: ALQ)
Latest News
Industrials Shares
ALS FY26 results: Record growth, leadership moves, digital push
ASX Share Market News
Why might Pro Medicus shares soon be under pressure?
Dividend Investing
15 ASX shares going ex-dividend before EOFY
Share Gainers
4 ASX 200 stocks rocketing higher this week
Broker Notes
3 ASX shares Morgans rates as buys this week
Share Gainers
Here are the top 10 ASX 200 shares today
Broker Notes
Buy, hold, sell: Endeavour and these popular ASX shares
Broker Notes
Buy this ASX 200 stock for a 21% return: Broker
Industrials Shares
Why is this ASX industrials stock edging higher today?
Industrials Shares
ALS reports record FY26 earnings and dividend uplift
ASX Share Market News
Why investors should buy the dip on this ASX industrials stock
Healthcare Shares
ALS reports cyber security incident impacting operations
Frequently Asked Questions
-
Yes, ALS Ltd historically pays two partially or fully franked dividends a year.
-
ALS Ltd generally pays its shareholder dividends in July and December
-
ALS Ltd listed on the ASX on 18 July 1952.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 12 Jun 2026 | $0.2310 | 30.00% | Final | 03 Jul 2026 |
| 26 Nov 2025 | $0.1940 | 29.90% | Interim | 17 Dec 2025 |
| 03 Jul 2025 | $0.1970 | 30.00% | Final | 25 Jul 2025 |
| 27 Nov 2024 | $0.1890 | 30.00% | Interim | 19 Dec 2024 |
| 12 Jun 2024 | $0.1960 | 20.00% | Final | 02 Jul 2024 |
| 23 Nov 2023 | $0.1960 | 20.00% | Interim | 14 Dec 2023 |
| 09 Jun 2023 | $0.1940 | 10.00% | Final | 06 Jul 2023 |
| 24 Nov 2022 | $0.2030 | 0.00% | Interim | 16 Dec 2022 |
| 06 Jun 2022 | $0.1700 | 30.00% | Final | 04 Jul 2022 |
| 02 Dec 2021 | $0.1580 | 30.00% | Interim | 17 Dec 2021 |
| 07 Jun 2021 | $0.1460 | 70.00% | Final | 05 Jul 2021 |
| 26 Nov 2020 | $0.0850 | 100.00% | Interim | 16 Dec 2020 |
| 05 Jun 2020 | $0.0610 | 70.00% | Final | 06 Jul 2020 |
| 27 Nov 2019 | $0.1150 | 30.00% | Interim | 16 Dec 2019 |
| 03 Jun 2019 | $0.1150 | 35.04% | Final | 01 Jul 2019 |
| 29 Nov 2018 | $0.1100 | 20.00% | Interim | 18 Dec 2018 |
| 06 Jun 2018 | $0.0900 | 40.00% | Final | 02 Jul 2018 |
| 29 Nov 2017 | $0.0800 | 40.00% | Interim | 18 Dec 2017 |
| 07 Jun 2017 | $0.0000 | 0.00% | Final | 03 Jul 2017 |
| 05 Dec 2016 | $0.0550 | 60.00% | Interim | 21 Dec 2016 |
| 08 Jun 2016 | $0.0600 | 40.00% | Final | 01 Jul 2016 |
| 03 Dec 2015 | $0.0750 | 25.07% | Interim | 18 Dec 2015 |
| 11 Jun 2014 | $0.2000 | 50.00% | Final | 02 Jul 2014 |
| 07 Jun 2013 | $0.2700 | 50.00% | Final | 02 Jul 2013 |
| 05 Jun 2009 | $0.4250 | 0.00% | Final | 01 Jul 2009 |
| 01 Dec 2008 | $0.4250 | 58.82% | Interim | 17 Dec 2008 |
| 06 Jun 2008 | $0.5100 | 58.82% | Final | 01 Jul 2008 |
| 30 Nov 2007 | $0.2975 | 58.82% | Interim | 17 Dec 2007 |
| 06 Jun 2007 | $0.3570 | 58.82% | Final | 02 Jul 2007 |
| 29 Nov 2006 | $0.2380 | 58.82% | Interim | 15 Dec 2006 |
| 05 Jun 2006 | $0.2900 | 100.00% | Final | 03 Jul 2006 |
| 25 Nov 2005 | $0.2100 | 100.00% | Interim | 20 Dec 2005 |
| 04 Jun 2004 | $0.1900 | 100.00% | Final | 01 Jul 2004 |
| 28 Nov 2003 | $0.1400 | 100.00% | Interim | 19 Dec 2003 |
ALQ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ALS Ltd
ALS Ltd (ASX: ALQ) is one of the world's largest laboratory testing, inspection, certification, and verification businesses. It operates from around 350 sites across 65 countries.
Listed on the ASX in 1952, ALS operates two reportable divisions: Commodities and Life Sciences. ALS's Commodities segment traditionally generates the majority of the company's underlying earnings. It provides geochemistry, metallurgy, inspection, and mine site services for the mining industry globally.
The company also provides environmental, pharmaceutical, and food and beverage testing and certification through its Life Sciences division. ALS Ltd has a multi-billion dollar market capitalisation and is part of the ASX 100.
ALQ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | $21.61 | $0.20 | 0.93% | 1,327,387 | $21.45 | $21.78 | $21.29 |
| 30 Jul 2026 | $21.41 | $0.17 | 0.80% | 2,030,723 | $21.21 | $21.77 | $20.94 |
| 29 Jul 2026 | $21.24 | $-0.58 | -2.66% | 2,962,106 | $22.00 | $22.00 | $21.11 |
| 28 Jul 2026 | $21.82 | $0.56 | 2.63% | 2,399,370 | $22.16 | $22.75 | $21.50 |
| 27 Jul 2026 | $21.26 | $0.80 | 3.91% | 2,205,563 | $20.84 | $21.39 | $20.64 |
| 24 Jul 2026 | $20.46 | $-1.68 | -7.59% | 2,632,177 | $21.98 | $22.03 | $20.46 |
| 23 Jul 2026 | $22.14 | $-0.19 | -0.85% | 1,617,704 | $22.46 | $22.83 | $22.07 |
| 22 Jul 2026 | $22.33 | $0.31 | 1.41% | 988,665 | $21.93 | $22.45 | $21.76 |
| 21 Jul 2026 | $22.02 | $0.22 | 1.01% | 847,134 | $21.76 | $22.13 | $21.52 |
| 20 Jul 2026 | $21.80 | $-0.16 | -0.73% | 1,093,119 | $21.95 | $22.13 | $21.58 |
| 17 Jul 2026 | $21.96 | $0.04 | 0.18% | 840,685 | $21.95 | $21.97 | $21.61 |
| 16 Jul 2026 | $21.92 | $-0.32 | -1.44% | 1,347,584 | $22.06 | $22.21 | $21.37 |
| 15 Jul 2026 | $22.24 | $0.13 | 0.59% | 607,914 | $22.25 | $22.39 | $22.14 |
| 14 Jul 2026 | $22.11 | $-0.21 | -0.94% | 843,389 | $22.18 | $22.28 | $21.75 |
| 13 Jul 2026 | $22.32 | $-0.22 | -0.98% | 1,048,352 | $22.24 | $22.61 | $22.15 |
| 10 Jul 2026 | $22.54 | $0.30 | 1.35% | 882,159 | $22.55 | $22.77 | $22.09 |
| 09 Jul 2026 | $22.24 | $-0.23 | -1.02% | 964,556 | $22.35 | $22.48 | $22.05 |
| 08 Jul 2026 | $22.47 | $-0.68 | -2.94% | 1,272,464 | $22.96 | $22.96 | $22.13 |
| 07 Jul 2026 | $23.15 | $-0.16 | -0.69% | 1,689,986 | $23.29 | $23.59 | $22.87 |
| 06 Jul 2026 | $23.31 | $-0.11 | -0.47% | 950,152 | $23.18 | $23.63 | $23.14 |
| 03 Jul 2026 | $23.42 | $0.57 | 2.49% | 1,133,846 | $23.10 | $23.42 | $22.71 |
| 02 Jul 2026 | $22.85 | $-0.18 | -0.78% | 2,667,728 | $23.02 | $23.13 | $22.78 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 01 Jul 2026 | Malcom Deane | Expiry | 49,181 | $1,132,638 |
As advised by the company. 468,509 rights, rights lapsed
|
| 01 Jul 2026 | Malcom Deane | Exercise | 145,177 | $3,343,426 |
Conversion of securities. 351,215 rights
|
| 01 Jul 2026 | Malcom Deane | Issued | 27,883 | $642,145 |
Issue of securities. 496,392 rights, per announcement
|
| 01 Jul 2026 | Malcom Deane | Buy | 145,177 | $3,343,426 |
Conversion of securities.
|
| 29 May 2026 | Catharine Farrow | Buy | 4,200 | $100,425 |
On-market trade.
|
| 27 May 2026 | Leslie Desjardins | Buy | 1,200 | $28,300 |
On-market trade.
|
| 02 Dec 2025 | Malcom Deane | Sell | 7,356 | $161,317 |
On-market trade. As per annouuncement on 05-12-2025
|
| 26 Aug 2025 | Siddhartha Kadia | Buy | 4,910 | $59,236 |
On-market trade. US$
|
| 14 Aug 2025 | Nigel Garrard | Buy | 1,328 | $24,966 |
On-market trade.
|
| 07 Aug 2025 | Erica Mann | Buy | 5,930 | $108,044 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Nigel David Garrard | Non-Executive DirectorNon-Executive Chairman | Jun 2023 |
Mr Garrard is an executive with a track record across the fast-moving consumer goods and industrial/manufacturing sectors. He has over 20 years' experience as an ASX-listed CEO across three companies. In 2019, he retired as Managing Director and CEO of Orora Limited. He led the demerger of Orora Limited from Amcor, and the subsequent listing of Orora Limited on ASX in 2013. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division, and Managing Director of SPC Ardmona. Nigel brings international experience across listed, not-for-profit, government and private entities. He is currently the Chairman of Ansell Limited, Chairman of Flinders Port Holdings Pty Ltd, Chairman of the McMahon Services advisory board, and Director of Treasury Wine Estates Limited.
|
| Ms Christina (Christy) Boyce | Non-Executive Director | Sep 2025 |
Ms Boyce has over 25 years' advisory experience in Australia and the United States, advising senior leadership across a range of industries including consumer and industrial goods, agribusiness and resources. Christy was a director (senior partner) of Port Jackson Partners. Prior to this, she was a partner at McKinsey & Co, working in the firm's Sydney, New York and Chicago offices. Throughout her career, Christy has worked with a range of growth companies focusing on strategy, organisational effectiveness and sales and marketing. Christy is currently a non-executive director of JB Hifi, BAI Communications Australia, EMM Consulting and a non-executive director of The Hunger Project Australia. She is a member of the Risk Committee, People Committee.
|
| Ms Leslie A Desjardins | Non-Executive Director | Nov 2019 |
Ms Desjardins has a background as a CFO and senior financial and governance professional in a range of multinational and global businesses. She has commercial and financial governance experience with multinational public companies in North America, Canada, and Australia each with global operations. Her areas of experience include CFO level executive and financial strategic leadership, M&A, corporate finance and treasury, governance, financial and tax compliance, and enterprise risk management. Leslie is currently a Director and Audit Committee member with Ansell Limited. During her executive career, Leslie served as Executive VP and CFO at Amcor Limited, a global leader in packaging of food, beverage, pharmaceutical and tobacco products. Prior to Amcor Ltd, Leslie served in financial and corporate strategic positions with General Motors Corporation, including Chief Financial Officer GM Holden Australia, Controller GM North America, Executive Director Manufacturing Finance and Director GM North America Strategy and Planning. She is the Chair of the Risk Committee, and a member of the People Committee.
|
| Dr Siddhartha Kadia | Non-Executive Director | Jan 2019 |
Dr Kadia has lived and worked in the US, Japan, China, and India and has more than 25 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors. Currently Siddhartha is CEO of Mesa Laboratories which commenced in April 2026. Siddhartha was formerly CEO and Director at Calibre Scientific, a privately held company that services life sciences tools industry and CEO of PhenomeX (Berkeley lights). In addition, he was President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego, California. Prior to EAG, Siddhartha served as President of the Life Sciences Division at Life Technologies Corporation (NSDQ: LIFE), a publicly traded life sciences tools company. Siddhartha was also a management consultant at McKinsey & Company where his work focused on life sciences and healthcare related engagements. He is the Chair and a member of the Sustainability & Innovation Committee, and a member of the People Committee.
|
| Ms Erica Mann | Non-Executive Director | Mar 2024 |
Ms Mann is a C-suite executive with a 30-year career across regulated, multi-channel and multi product environment in top DAX, NYSE, NASDAQ pharmaceutical, OTC and FMCG multinationals. Before retiring as an executive, Erica led Bayer's Consumer Health Division, one of the OTC companies. Prior to joining Bayer, she was President and General Manager of Pfizer Nutrition following its acquisition of Wyeth Inc, where she served as Senior Vice President of Global Nutrition. This followed other senior executive roles of other Fortune 500 companies including Eli Lily and Johnson & Johnson. She has held leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland and the US. In addition to her executive experience in the nutrition and health industry, Erica has experience with global and emerging markets across Africa, China, Russia, and Brazil. Erica currently serves as an independent director of Kenvue and DSM-Firmenich. Erica was educated in South Africa and obtained diplomas in analytical chemistry (Tswane University, Pretoria), marketing management (IMM, Johannesburg), and small business development (SBDC -Johannesburg). She is a member of the Sustainability & Innovation Committee.
|
| Mr Peter Possemiers | Non-Executive Director | Nov 2022 |
Mr Possemiers has a background as a TIC sector expert with almost 40 years' experience working as a senior executive in leadership roles globally for SGS. He has lead teams both regionally and globally most notably SGS's global Environment Health and Safety business, then a CHF 550 million business with a global headcount which exceeded 6000. As Executive Vice President, he was a member of the SGS Operations Council with responsibility for the strategic growth and profitability of the business, leading 15 strategic acquisitions. He is the Chair of the People Committee, and a member of the Risk Committee.
|
| Mr Malcom Deane | Chief Strategy Officer General Manager Life Sciences - Food & Pharma Americas GeneralChief Executive OfficerManaging Director | Mar 2023 |
Mr Deane has served the company in leadership positions for the past 10 years in such roles as General Manager for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions.
|
| Ms Catharine Farrow | Non-Executive Director | Mar 2025 |
Dr Farrow has more than 30 years of mining industry experience in all aspects of exploration, development, technical services, acquisitions, company building, operations, board governance and innovation/technology. Her experience ranges from the High Arctic to equatorial environments in base, critical and precious metals. Catharine also serves as a director of Franco-Nevada Corporation and is lead director of Aclara Resources Inc. She is a Member of the Board of Governors of Laurentian University. She is also in the mining and technology industries in both public and private companies, and academia as President of FarExGeoMine Ltd., where she provides advisory support in technical, governance, innovation and technology, organisational structure and as a witness. Catharine's executive career includes the role of Founding CEO and member of the Board of Directors of TMAC Resources Inc a public mining company based in Toronto. Previously she had been COO of KGHM International and held other executive roles in precursor companies from 2003 to 2012 including as Chief Technology Officer and Senior Vice President Corporate Development and Technical Services (including joint ventures, M&A opportunities, and strategy). She is a member of the Sustainability & Innovation Committee.
|
| Ms Dayna Field | Company SecretaryGeneral Counsel | Oct 2024 |
-
|
| Stuart Hutton | Chief Financial Officer |
-
|
|
| Dayna Field | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 161,719,043 | 31.86% |
| J P Morgan Nominees Australia Pty Limited | 82,964,814 | 16.35% |
| Citicorp Nominees Pty Limited | 82,631,353 | 16.28% |
| BNP Paribas Noms Pty Ltd. | 23,719,300 | 4.67% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 8,518,977 | 1.68% |
| Faircase Pty Ltd. | 8,452,085 | 1.67% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 5,836,951 | 1.15% |
| Australian Foundation Investment Company Limited | 5,540,000 | 1.09% |
| Argo Investments Limited | 5,050,000 | 1.00% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 4,419,932 | 0.87% |
| HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 4,175,914 | 0.82% |
| WHSP Holdings Pty Limited | 3,303,306 | 0.65% |
| Buttonwood Nominees Pty Ltd | 2,600,000 | 0.51% |
| Netwealth Investments Limited <Wrap Services A/C> | 2,274,650 | 0.45% |
| Ms Maryon Catherine Campbell <The Checkmate A/C> | 1,836,273 | 0.36% |
| UBS Nominees Pty Ltd. | 1,177,483 | 0.23% |
| Mutual Trust Pty Ltd | 1,128,569 | 0.22% |
| BNP Paribas Noms (NZ) Ltd. | 1,123,820 | 0.22% |
| Certane CT Pty Ltd <ALS LTI A/C> | 1,080,489 | 0.21% |
| Merrill Lynch (Australia) Nominees Pty Ltd | 1,058,225 | 0.21% |